Pages that link to "Q48189941"

The following pages link to Magnetic resonance outcome of new enhancing lesions in patients with relapsing-remitting multiple sclerosis (Q48189941):

Displaying 21 items.

• Imaging of multiple sclerosis: role in neurotherapeutics (Q30989935) (← links)
• The effect of interferon-beta on black holes in patients with multiple sclerosis (Q31120372) (← links)
• Multiple sclerosis lesions: insights from imaging techniques (Q33505423) (← links)
• The effect of hypointense white matter lesions on automated gray matter segmentation in multiple sclerosis (Q33698702) (← links)
• Shifting imaging targets in multiple sclerosis: from inflammation to neurodegeneration (Q34303664) (← links)
• A Population Approach to Characterize Interferon Beta-1b Effect on Contrast Enhancing Lesions in Patients With Relapsing Remitting Multiple Sclerosis (Q35676048) (← links)
• Characterizing contrast-enhancing and re-enhancing lesions in multiple sclerosis. (Q35937975) (← links)
• Neuroradiological evaluation of demyelinating disease (Q36999734) (← links)
• Use of Magnetic Resonance Imaging as Well as Clinical Disease Activity in the Clinical Classification of Multiple Sclerosis and Assessment of Its Course: A Report from an International CMSC Consensus Conference, March 5-7, 2010 (Q38181064) (← links)
• Tracking the Evolution of Cerebral Gadolinium-Enhancing Lesions to Persistent T1 Black Holes in Multiple Sclerosis: Validation of a Semiautomated Pipeline. (Q38859250) (← links)
• The effect of inflammation and its reduction on brain plasticity in multiple sclerosis: MRI evidence (Q41498767) (← links)
• Tissue-specific imaging is a robust methodology to differentiate in vivo T1 black holes with advanced multiple sclerosis-induced damage. (Q41687816) (← links)
• Lesion-to-ventricle distance and other risk factors for the persistence of newly formed black holes in relapsing-remitting multiple sclerosis (Q46866052) (← links)
• An exploratory study on interferon beta dose effect in reducing size of enhancing lesions in multiple sclerosis (Q47292356) (← links)
• Lesions by tissue specific imaging characterize multiple sclerosis patients with more advanced disease (Q48974386) (← links)
• Persistent T1 hypointensity as an MRI marker for treatment efficacy in multiple sclerosis. (Q49108072) (← links)
• Diagnostic value of brain chronic black holes on T1-weighted MR images in clinically isolated syndromes (Q57601812) (← links)
• Differences in Intercellular Communication During Clinical Relapse and Gadolinium-Enhanced MRI in Patients With Relapsing Remitting Multiple Sclerosis: A Study of the Composition of Extracellular Vesicles in Cerebrospinal Fluid (Q59333230) (← links)
• The effect of interferon beta-1b on size of short-lived enhancing lesions in patients with multiple sclerosis (Q61413376) (← links)
• Cost-analysis of relapsing-remitting multiple sclerosis in Italy after the introduction of new disease-modifying agents (Q80363848) (← links)
• Comparing MRI metrics to quantify white matter microstructural damage in multiple sclerosis (Q92495060) (← links)